What’s the Latest?

Learn About Treatment    |    Training Videos    >    What’s the Latest?


What’s the Latest? Xylazine

Presenter(s): Mary Figgatt, PhD Candidate (UNC) and Don Jackson (North Carolina Survivors Union)
Date: February 2023
Shareable link to this video

Xylazine is a veterinary tranquilizer that has been found mixed with other drugs like fentanyl and heroin. Evidence indicates overdose deaths involving xylazine have increased throughout the United States with the largest impact occurring in the Northeast and Puerto Rico. This webinar includes presenters from the North Carolina Survivors Union, who shared their experience responding to xylazine in their region.




What’s the Latest? Methamphetamine and Psychosis

Presenter(s): Jonathan Buchholz, MD
Date: March 2024
Shareable link to this video

Description
With the growing use of methamphetamine, methamphetamine associated psychosis is a problem that more and more providers are seeing. This problem can impact the ability of patients to engage with treatment providers and recommended treatments for medical, psychiatric, and addiction issues. This talk will describe what methamphetamine associated psychosis is and how it differs or does not differ from an underlying psychotic disorder. We will also spend time describing evidence-based approaches to addressing these symptoms and promote engagement and retention in care.

Speaker
After earning his medical degree, Dr. Buchholz continued at the University of Washington to complete his general psychiatry residency and addiction psychiatry fellowship. He is medical director of inpatient psychiatry at the VA Puget Sound and director of the Addiction Psychiatry Fellowship at the University of Washington. He spends most of his clinical time on the inpatient psychiatry and the addiction consultation services caring for patients with co-occurring disorders at the Seattle VA. Dr. Buchholz is an assistant professor at the University of Washington with academic interests centered around improvement of education for substance use disorders to medical students, psychiatry residents, and addiction fellows. Dr. Buchholz has earned several teaching awards from the medical school, the general psychiatry residency, and the psychiatry and behavioral sciences department at the University of Washington.




What’s the Latest? Boston Medical Center Roundhouse: A Post-Overdose Stabilization Center

Presenter(s): Miriam Komaromy, MD, FACP, DFASAM
Date: June 2023
Shareable link to this video

Boston Medical Center created this first of its kind innovative center to provide SUD crisis and overdose stabilization. Services include a low-barrier SUD-focused clinic offering walk-in urgent care, medications for SUD, infection screening and prevention, and a 24/7 short-stay stabilization unit to manage over-intoxication, withdrawal, and complications of substance use (e.g., abscesses, HIV risk, psychosis) that is not contingent upon abstinence.

Speaker
Dr. Komaromy is the Medical Director of the Grayken Center for Addiction, Boston Medical Center, Boston University. Dr. Komaromy is Board Certified in Addiction Medicine and Internal Medicine. She has extensive clinical, educational, evaluation, and leadership experience related to treatment of substance use disorders. As Medical Director for the Grayken Center for Addiction at Boston Medical Center, she oversees the study and treatment of Substance Use Disorders, as well as local and national policy and advocacy work to improve the care of people who have substance use disorders. In the past, Dr. Komaromy has served as the medical director of a state-funded addiction treatment hospital, has led programs in the US and internationally to train primary care providers in treatment of addiction, and has implemented treatment programs for people who are experiencing homelessness and have substance use disorders. She is the Vice President of AMERSA, a leading interdisciplinary addiction treatment professional organization, and has served on the national board of the American Society of Addiction Medicine.




What’s the Latest? Drug Trends

Presenter(s): Caleb Banta-Green, MSW, MPH, PhD
Date: November 2023
Shareable link to this video

Drug Trends with Caleb Banta-Green, PhD, MPH, MSW, will provide an overview of on current drug trends in Washington State with a focus on fentanyl, methamphetamine and overdoses. Data sources will include qualitative interviews and surveys with people who use drugs, drug testing results from community drug checking networks at harm reduction locations, police evidence testing, and overdose mortality.




What’s the Latest? Navigating Hepatitis C Care: Insights from Washington State

Presenter(s): Jonathan Stockton, MHA
Date: May 2024
Shareable link to this video

Join us for a webinar addressing the critical issue of Hepatitis C linkages to care in Washington, in alignment with State’s goal to be Hep C-free by 2030. We will review the current state of Hepatitis C in the region, discuss opportunities for viral eradication, and highlight strategies to integrate Hepatitis C treatment into primary care, with a focus on leveraging opioid treatment as an opportunity to screen and treat people with histories of substance use.

Our speakers include representatives from the Washington State Department of Health, who will provide an overview of the current Hepatitis C landscape in Washington. Following this presentation, we will host a panel discussion featuring clinicians from Peninsula Community Health Services and Harborview Medical Center. Panelists will share their experiences and strategies for successfully integrating Hepatitis C treatment into primary care within their respective settings.